v3.25.1
Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net loss $ (12,287,461) $ (7,794,690)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 657,649 522,082
Increase (decrease) in cash resulting from changes in:    
Prepaid expenses and other current assets 168,181 162,695
Accounts payable (108,512) 369,326
Accrued and other current liabilities 407,195 331,656
Total adjustments to reconcile net loss to cash used in operations 1,124,513 1,385,759
Net cash used in operating activities (11,162,948) (6,408,931)
Cash flows from financing activities:    
Proceeds from issuance of Common Stock, pre-funded warrants, and warrants, net of issuance costs 6,886,102 7,605,625
Proceeds from exercise of pre-funded warrants 1,109 187
Payment for fractional shares in reverse stock split (828) (40)
Net cash provided by financing activities 6,886,383 7,605,772
Net increase (decrease) in cash and cash equivalents (4,276,565) 1,196,841
Cash and cash equivalents at beginning of period 7,438,135 6,241,294
Cash and cash equivalents at end of period 3,161,570 7,438,135
Supplemental disclosure:    
Cash paid for taxes 950 950
Non-cash financing activities:    
Incremental fair value of March 2023 warrant modification 0 144,765
Incremental fair value of November 2023 warrant inducement 0 2,995,343
Issuance of abeyance shares 18 0
Incremental fair value of May 2024 warrant inducement 1,526,232  
Issuance costs in accounts payable $ 50,495 $ 0

Source